Polynucleotide matrix-based method of identifying microorganisms
Abstract
Method of identifying microbial organisms wherein a biological sample containing nucleic acids is hybridized with a collection of polynucleotide probes, each probe having binding specificity for the ribosomal nucleic acids of at least one microbe. The collection of probes is organized into a series of "addresses" that provide information about the presence or absence of one or more polynucleotide sequences in the biological sample. Probes in the matrix are selected to distinguish between organisms that differ from each other by a known phylogenetic relationship. Advantageously, the invented method can detect and resolve the identities of microorganisms that are present in a mixed culture. The system is particularly suited to automated analysis.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A device for detecting nucleic acids, comprising
a solid support; and
a plurality of addresses disposed on the solid support, each address comprising at least one detectably labeled probe that hybridizes ribosomal nucleic acids from at least one microbial species under high stringency hybridization conditions, said plurality of addresses comprising,
a pan-bacterial address,
a higher-order address,
wherein said higher-order address is a pan-fungal address that specifically hybridizes ribosomal nucleic acids from a plurality of fungal species,
an intermediate-order address, and
a lower-order address,
wherein the lower-order address hybridizes ribosomal nucleic acids from a subset of organisms having ribosomal nucleic acids that hybridize at the intermediate-order address,
wherein the intermediate-order address hybridizes ribosomal nucleic acids from a subset of organisms having ribosomal nucleic acids that hybridize at the higher-order address, and
wherein at least one of said intermediate-order address and said lower-order address further comprise a detectably labeled probe that hybridizes ribosomal nucleic acids from a microbial species having ribosomal nucleic acids that hybridize at the pan-bacterial address.
2. A device for detecting nucleic acids, comprising:
a solid support; and
a plurality of addresses disposed on the solid support, each address comprising at least one detectably labeled probe that hybridizes ribosomal nucleic acids from at least one microbial species under high stringency hybridization conditions, said plurality of addresses comprising,
a pan-fungal address that specifically hybridizes ribosomal nucleic acids from a plurality of fungal species;
a higher-order address,
wherein said higher-order address is a pan-bacterial address that specifically hybridizes ribosomal nucleic acids from a plurality of species of Gram (+) bacteria, a plurality of species of bacteria in the family Enterobacteriaceae, a plurality of species of bacteria in the genus Enterococcus , a plurality of species of bacteria in the genus Staphylococcus , and a plurality of species of bacteria in the genus Campylobacter,
a first intermediate-order address, and
a first lower-order address,
wherein the first lower-order address hybridizes ribosomal nucleic acids from a subset of organisms having ribosomal nucleic acids that hybridize at the first intermediate-order address,
wherein the first intermediate-order address hybridizes ribosomal nucleic acids from a subset of organisms having ribosomal nucleic acids that hybridize at the higher-order address, and
wherein said first lower-order address further comprises a detectably labeled probe that
hybridizes ribosomal nucleic acids from a microbial species having ribosomal nucleic acids that hybridize at the higher-order address
but does not hybridize ribosomal nucleic acids from any microbial species having ribosomal nucleic acids that hybridize at said first intermediate-order address.
3. The device of either claim 1 or claim 2 , wherein the solid support is selected from the group consisting of a multiwell plate, and a plurality of individual tubes each maintained in a spaced-apart configuration.
4. The device of claim 1 , wherein the intermediate-order address specifically hybridizes ribosomal nucleic acids from a plurality of Candida species comprising Candida albicans, Candida tropicalis, Candida dubliniensis, Candida viswanathii and Candida parapsilosis , and wherein the lower-order address specifically hybridizes ribosomal nucleic acids from Candida albicans and Candida dubliniensis but not Candida tropicalis, Candida viswanathii or Candida parapsilosis.
5. The device of claim 1 or claim 2 , wherein each of said at least one detectably labeled probe is labeled with an acridinium ester.
6. The device of claim 1 , wherein each of said at least one detectably labeled probes is at least one detectably labeled soluble probe.
7. The device of claim 1 , wherein said intermediate-order address specifically hybridizes ribosomal nucleic acids of Candida species comprising Candida albicans and Candida dubliniensis.
8. The device of claim 7 , wherein said lower-order address specifically hybridizes ribosomal nucleic acids of Candida albicans.
9. The device of claim 1 , wherein said intermediate-order address specifically hybridizes ribosomal nucleic acids of Candida species comprising Candida albicans, Candida dubliniensis, Candida tropicalis, Candida viswanathii and Candida parapsilosis.
10. The device of claim 9 , wherein said lower-order address specifically hybridizes ribosomal nucleic acids of Candida albicans.
11. The device of claim 2 , wherein said first intermediate-order address is selected from the group consisting of a Gram (+) address that specifically hybridizes ribosomal nucleic acids of a plurality of Gram (+) bacteria, wherein said plurality of Gram (+) bacteria comprise a plurality of bacteria in the genus Staphylococcus , a plurality of bacteria in the genus Enterococcus , and a plurality of Actinomycetes bacteria in the High(G+C) subset of Gram (+) bacteria, a family Enterobacteriaceae address that specifically hybridizes ribosomal nucleic acids from a plurality of bacteria in the family Enterobacteriaceae, a Staphylococcus genus address that specifically hybridizes ribosomal nucleic acids from a plurality of species in the Staphylococcus genus, a genus Enterococcus address that specifically hybridizes ribosomal nucleic acids from a plurality of species in the genus Enterococcus , and a Campylobacter address that specifically hybridizes ribosomal nucleic acids from a plurality of Campylobacter species.
12. The device of claim 11 , wherein the first intermediate-order address is the Gram (+) address, and wherein the first lower-order address is an address that specifically hybridizes ribosomal nucleic acids from a plurality of Mycobacterium species.
13. The device of claim 12 , wherein said plurality of Mycobacterium species comprises Mycobacterium tuberculosis, Mycobacterium bovis, Mycobacterium bovis BCG and Mycobacterium africanum.
14. The device of claim 11 , wherein the first intermediate-order address is the Gram (+) address, and wherein the first lower-order address is an address that specifically hybridizes ribosomal nucleic acids of Streptococcus pneumoniae.
15. The device of claim 11 , wherein the first intermediate-order address is the Gram (+) address, and wherein the first lower-order address is an address that specifically hybridizes ribosomal nucleic acids from Listeria monocytogenes.
16. The device of claim 11 , wherein the first intermediate-order address is the Gram (+) address, and wherein the first lower-order address is an address that specifically hybridizes ribosomal nucleic acids of Staphylococcus aureus.
17. The device of claim 11 , wherein the first intermediate-order address is the family Enterobacteriaceae address, and wherein the first lower-order address is an E. coli address that specifically hybridizes ribosomal nucleic acids of E. coli.
18. The device of claim 11 , wherein the first intermediate-order address is the Staphylococcus genus address, and wherein the first lower-order address is a Staphylococcus aureus address that specifically hybridizes ribosomal nucleic acids from Staphylococcus aureus.
19. The device of claim 11 , wherein the first intermediate-order address is the genus Enterococcus address.
20. The device of claim 11 , wherein the first intermediate-order address is the Campylobacter address.
21. The device of claim 11 , wherein the first intermediate-order address is the Gram (+) address, and wherein the first lower-order address is an Actinomycetes address that specifically hybridizes ribosomal nucleic acids of a plurality of bacteria belonging to the High (G+C) subset of Gram (+) bacteria, wherein said plurality of bacteria belonging to the High(G+C) subset of Gram (+) bacteria comprise a plurality of bacteria in the genus Corynebacterium and a plurality of bacteria in the genus Mycobacterium.
22. The device of claim 21 , wherein said plurality of addresses further includes an address that hybridizes ribosomal nucleic acids from bacteria in the family Enterobacteriaceae.
23. The device of claim 22 , wherein said plurality of addresses further includes an address that hybridizes ribosomal nucleic acids from Enterococcus bacteria.
24. The device of claim 23 , wherein said plurality of addresses further includes an address that hybridizes ribosomal nucleic acids from bacteria in the Staphylococcus genus and an address that hybridizes ribosomal nucleic acids from a plurality of bacteria in the genus Campylobacter.
25. The device of claim 24 , wherein said plurality of addresses further includes at least one address that specifically hybridizes ribosomal nucleic acids from a single microorganism species.
26. The device of claim 25 , wherein said single microorganism species is selected from the group consisting of Escherichia coli, Streptococcus pneumoniae, Pseudomonas aeruginosa, Candida albicans and Staphylococcus aureus.
27. The device of claim 21 , wherein said plurality of addresses further includes an address that hybridizes ribosomal nucleic acids from Enterococcus bacteria.
28. The device of claim 21 , further comprising a single address that hybridizes ribosomal nucleic acids of Enterococcus bacteria and ribosomal nucleic acids from bacteria in the family Enterobacteriaceae.
29. The device of claim 28 , wherein said plurality of addresses further includes a single address that hybridizes ribosomal nucleic acids from bacteria in the Staphylococcus genus and ribosomal nucleic acids from a plurality of bacteria in the genus Campylobacter.
30. The device of claim 29 , wherein said plurality of addresses further includes a plurality of addresses that individually hybridize ribosomal nucleic acids from a plurality of microorganism species.
31. The device of claim 21 , wherein said plurality of addresses further includes an address that hybridizes ribosomal nucleic acids from bacteria in the Staphylococcus genus.
32. The device of claim 31 , wherein said plurality of addresses further includes an address that hybridizes ribosomal nucleic acids from a plurality of bacteria in the genus Campylobacter.
33. The device of claim 21 , wherein said plurality of addresses further includes an address that hybridizes ribosomal nucleic acids from a plurality of bacteria in the genus Campylobacter.
34. The device of claim 21 , wherein the pan-bacterial address comprises a polynucleotide probe having a sequence selected from the group consisting of SEQ ID NO: 1 and SEQ ID NO:58.
35. The device of claim 21 , wherein the pan-fungal address comprises a polynucleotide probe having the sequence of SEQ ID NO:4.
36. The device of claim 21 , wherein the Gram (+) address comprises a polynucleotide probe having the sequence of SEQ ID NO:7.
37. The device of claim 21 , wherein the Actinomycetes address comprises a polynucleotide probe having the sequence of SEQ ID NO: 10.
38. The device of claim 21 , wherein the pan-bacterial address comprises a polynucleotide probe having a sequence selected from the group consisting of SEQ ID NO: 1 and SEQ ID NO:58, wherein the pan-fungal address comprises a polynucleotide probe having the sequence of SEQ ID NO:4, wherein the Gram (+) address comprises a polynucleotide probe having the sequence of SEQ ID NO:7, and wherein the Actinomycetes address comprises a polynucleotide probe having the sequence of SEQ ID NO:10.
39. The device of claim 2 , wherein each of said at least one detectably labeled probes is at least one detectably labeled soluble probe.
40. A device for detecting nucleic acids, comprising:
a solid support; and
a plurality of addresses disposed on the solid support, each address comprising at least one detectably labeled probe that hybridizes ribosomal nucleic acids from at least one microbial species under high stringency hybridization conditions, said plurality of addresses comprising,
a pan-fungal address that specifically hybridizes ribosomal nucleic acids from a plurality of fungal species,
a higher-order address,
wherein said higher-order address is a pan-bacterial address that specifically hybridizes ribosomal nucleic acids from a plurality of species of Gram (+) bacteria, a plurality of species of bacteria in the family Enterobacteriaceae, a plurality of species of bacteria in the genus Enterococcus , a plurality of species of bacteria in the genus Staphylococcus , and a plurality of species of bacteria in the genus Campylobacter,
an intermediate-order address, and
a lower-order address,
wherein the lower-order address hybridizes ribosomal nucleic acids from a subset of organisms having ribosomal nucleic acids that hybridize at the intermediate-order address,
wherein the intermediate-order address hybridizes ribosomal nucleic acids from a subset of organisms having ribosomal nucleic acids that hybridize at the higher-order address, and
wherein at least one of said intermediate-order address and said lower-order address further comprise a detectably labeled probe that hybridizes ribosomal nucleic acids from a microbial species having ribosomal nucleic acids that hybridize at the pan-fungal address.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.